267 related articles for article (PubMed ID: 9327730)
1. Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries.
Wight TN; Lara S; Riessen R; Le Baron R; Isner J
Am J Pathol; 1997 Oct; 151(4):963-73. PubMed ID: 9327730
[TBL] [Abstract][Full Text] [Related]
2. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries.
Riessen R; Isner JM; Blessing E; Loushin C; Nikol S; Wight TN
Am J Pathol; 1994 May; 144(5):962-74. PubMed ID: 8178945
[TBL] [Abstract][Full Text] [Related]
3. Matrix proteoglycans and remodelling of interstitial lung tissue in lymphangioleiomyomatosis.
Merrilees MJ; Hankin EJ; Black JL; Beaumont B
J Pathol; 2004 Jun; 203(2):653-60. PubMed ID: 15141380
[TBL] [Abstract][Full Text] [Related]
4. Versican in human fetal skin development.
Sorrell JM; Carrino DA; Baber MA; Caplan AI
Anat Embryol (Berl); 1999 Jan; 199(1):45-56. PubMed ID: 9924934
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of extracellular matrix proteoglycans and collagen type I in human crescentic glomerulonephritis.
Stokes MB; Hudkins KL; Zaharia V; Taneda S; Alpers CE
Kidney Int; 2001 Feb; 59(2):532-42. PubMed ID: 11168935
[TBL] [Abstract][Full Text] [Related]
6. Proteoglycan deposition in pulmonary fibrosis.
Bensadoun ES; Burke AK; Hogg JC; Roberts CR
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1819-28. PubMed ID: 8970376
[TBL] [Abstract][Full Text] [Related]
7. Serial extracellular matrix changes in neointimal lesions of human coronary artery after percutaneous transluminal coronary angioplasty: clinical significance of early tenascin-C expression.
Imanaka-Yoshida K; Matsuura R; Isaka N; Nakano T; Sakakura T; Yoshida T
Virchows Arch; 2001 Aug; 439(2):185-90. PubMed ID: 11561759
[TBL] [Abstract][Full Text] [Related]
8. The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype.
Kinsella MG; Bressler SL; Wight TN
Crit Rev Eukaryot Gene Expr; 2004; 14(3):203-34. PubMed ID: 15248816
[TBL] [Abstract][Full Text] [Related]
9. Proteoglycans in granulomatous lung diseases.
Bensadoun ES; Burke AK; Hogg JC; Roberts CR
Eur Respir J; 1997 Dec; 10(12):2731-7. PubMed ID: 9493652
[TBL] [Abstract][Full Text] [Related]
10. Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion.
Kolodgie FD; Burke AP; Farb A; Weber DK; Kutys R; Wight TN; Virmani R
Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1642-8. PubMed ID: 12377743
[TBL] [Abstract][Full Text] [Related]
11. Comparison of deposits of versican, biglycan and decorin in saphenous vein and internal thoracic, radial and coronary arteries: correlation to patency.
Merrilees MJ; Beaumont B; Scott LJ
Coron Artery Dis; 2001 Feb; 12(1):7-16. PubMed ID: 11211169
[TBL] [Abstract][Full Text] [Related]
12. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells.
Evanko SP; Angello JC; Wight TN
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1004-13. PubMed ID: 10195929
[TBL] [Abstract][Full Text] [Related]
13. The soft tissue cover of the mandibular condyle. Differentiation in histological forms and age-related changes of aggrecan- and versican-like proteoglycans.
Müller K; Primm T; Dannhauer KH
J Orofac Orthop; 1998; 59(6):371-87. PubMed ID: 9857606
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein lipase enhances the binding of native and oxidized low density lipoproteins to versican and biglycan synthesized by cultured arterial smooth muscle cells.
Olin KL; Potter-Perigo S; Barrett PH; Wight TN; Chait A
J Biol Chem; 1999 Dec; 274(49):34629-36. PubMed ID: 10574927
[TBL] [Abstract][Full Text] [Related]
15. Smooth muscle cell expression of extracellular matrix genes after arterial injury.
Nikkari ST; Järveläinen HT; Wight TN; Ferguson M; Clowes AW
Am J Pathol; 1994 Jun; 144(6):1348-56. PubMed ID: 8203472
[TBL] [Abstract][Full Text] [Related]
16. Differences in the distribution of versican, decorin, and biglycan in atherosclerotic human coronary arteries.
Gutierrez P; O'Brien KD; Ferguson M; Nikkari ST; Alpers CE; Wight TN
Cardiovasc Pathol; 1997 Sep; 6(5):271-8. PubMed ID: 25989722
[TBL] [Abstract][Full Text] [Related]
17. Wound healing: a paradigm for lumen narrowing after arterial reconstruction.
Geary RL; Nikkari ST; Wagner WD; Williams JK; Adams MR; Dean RH
J Vasc Surg; 1998 Jan; 27(1):96-106; discussion 106-8. PubMed ID: 9474087
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of extracellular matrix components in human breast tumours with special reference to PG-M/versican.
Nara Y; Kato Y; Torii Y; Tsuji Y; Nakagaki S; Goto S; Isobe H; Nakashima N; Takeuchi J
Histochem J; 1997 Jan; 29(1):21-30. PubMed ID: 9088942
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical study of proteoglycans in vocal folds.
Pawlak AS; Hammond T; Hammond E; Gray SD
Ann Otol Rhinol Laryngol; 1996 Jan; 105(1):6-11. PubMed ID: 8546427
[TBL] [Abstract][Full Text] [Related]
20. Biglycan, decorin, and versican protein expression patterns in coronary arteriopathy of human cardiac allograft: distinctness as compared to native atherosclerosis.
Lin H; Wilson JE; Roberts CR; Horley KJ; Winters GL; Costanzo MR; McManus BM
J Heart Lung Transplant; 1996 Dec; 15(12):1233-47. PubMed ID: 8981209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
